This article discusses the Appeals Court Panel’s decision to uphold the District Court’s ruling that the St. Luke’s-Saltzer acquisition was anticompetitive. The article focuses on the Panel’s views on efficiencies and also comments on its discussion of the implications for ancillary services.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...